MedPath

Triamcinolone

Generic Name
Triamcinolone
Brand Names
Allernaze, Aristocort, Aristocort R, Juulissa Pharmapak, Kenalog, Kourzeq, Marcaine, Nasacort, Oracort, Oralone, Pediaderm Ta, Triaderm, Trianex, Triderm, Triesence, Triloan Suik, Tritocin, Viaderm Kc, Xipere, Zilretta
Drug Type
Small Molecule
Chemical Formula
C21H27FO6
CAS Number
124-94-7
Unique Ingredient Identifier
1ZK20VI6TY
Background

Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly seen in the forms triamcinolone hexacetonide, triamcinolone acetonide, and triamcinolone diacetate.

Triamcinolone was granted FDA approval on 3 December 1957. In October 2021, a suspension of triamcinolone acetonide was approved for suprachoroidal injection - the first suprachoroidal injection to receive FDA approval - for the treatment of patients with macular edema associated with uveitis.

Indication

肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱,故一般不用作肾上腺皮质功能减退的替代治疗。

Associated Conditions
Acne, Acne Vulgaris, Acute Gouty Arthritis, Allergic Contact Dermatitis, Allergic Rhinitis (AR), Allergic Skin Reaction, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aphthous Stomatitis, Asthma, Atopic Dermatitis, Autoimmune Hemolytic Anemia, Berylliosis, Bullous dermatitis herpetiformis, Chronic Eczema, Chronic Inflammatory Skin Diseases, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Crohn's Disease (CD), Dental Cavity, Dermatitis, Dermatomyositis (DM), Diaper Rash, Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Erythroderma, Fungal Infections, Fungal infectious disorders of the Beard, Fungal skin infection, Gingivitis, Haemorrhoids, Hemangiomas, Hypercalcemia, Inflammation of Mouth, Intertrigo, Itching of the Anus, Itching of the External Genitalia, Itching of the Foot, Itching of the genitals, Itching of the hand, Juvenile Idiopathic Arthritis (JIA), Keloids Scars, Leukemias, Lichen Planus (LP), Lichen simplex chronicus, Lymphoma, Macular Edema, Mycosis Fungoides (MF), Mycotic Eczema, Necrobiosis lipoidica diabeticorum, Neurodermatitis, Nummular Dermatitis, Ocular Inflammation, Ophthalmia, Sympathetic, Oral Erosive Lichen Planus, Otitis Externa, Pemphigus, Pericarditis, Polymyositis, Postherpetic Neuralgia, Primary adrenocortical insufficiency, Proteinuria, Psoriasis Vulgaris (Plaque Psoriasis), Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Purulent Wounds, Pyoderma caused by susceptible bacteria, Regional Enteritis, Rheumatoid Arthritis, Ringworm Folliculitis, Seborrheic Dermatitis, Seborrheic Dermatitis, Eczematous, Secondary Impetiginization, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Serum Sickness, Skin chapped, Stomatitis, Denture, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Tinea Corporis, Transfusion Reactions, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Urticaria, Uveitis, Wound Infections, Acute Bursitis, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Corticosteroid-responsive dermatoses, Cutaneous candidiasis, Cystic tumour of the ganglia, Exfoliative erythroderma, Granuloma annulare lesions, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Oral infections, Oral lesions, Severe Erythema multiforme, Subacute Dermatitis, Eczematous, Symptomatic Sarcoidosis, Ulceration of the mouth, Ulcerative stomatitis

Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation

Phase 3
Completed
Conditions
Diabetic Retinopathy
Diabetic Macular Edema
DME
First Posted Date
2005-03-14
Last Posted Date
2017-07-02
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
5
Registration Number
NCT00105404
Locations
🇺🇸

National Eye Institute (NEI), Bethesda, Maryland, United States

The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

Phase 3
Completed
Conditions
Retinal Vein Occlusion
Macular Edema, Cystoid
Interventions
First Posted Date
2005-03-04
Last Posted Date
2018-07-02
Lead Sponsor
The Emmes Company, LLC
Target Recruit Count
682
Registration Number
NCT00105027
Locations
🇺🇸

University of Wisconsin, Madison, Wisconsin, United States

Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders

Phase 1
Completed
Conditions
Macular Degeneration
Retinal Vein Occlusion
Diabetic Retinopathy
First Posted Date
2005-01-13
Last Posted Date
2017-07-02
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
120
Registration Number
NCT00101764
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration

Phase 3
Completed
Conditions
Macular Degeneration
First Posted Date
2004-12-22
Last Posted Date
2017-07-02
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
30
Registration Number
NCT00100009
Locations
🇺🇸

Doheny Eye Institute, Los Angeles, California, United States

🇺🇸

Wills Eye Hospital, Philadelphia, Pennsylvania, United States

🇺🇸

Southeastern Retina Associates (SRAKT), Knoxville, Tennessee, United States

and more 19 locations

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Phase 2
Completed
Conditions
Precancerous/Nonmalignant Condition
Non-melanomatous Skin Cancer
First Posted Date
2004-02-16
Last Posted Date
2018-09-11
Lead Sponsor
University of Arizona
Registration Number
NCT00021294
Locations
🇺🇸

Arizona Cancer Center, Tucson, Arizona, United States

Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders

Phase 1
Completed
Conditions
Macular Degeneration
Retinal Vein Occlusion
First Posted Date
2003-10-16
Last Posted Date
2017-07-02
Lead Sponsor
National Eye Institute (NEI)
Target Recruit Count
16
Registration Number
NCT00071227
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Lung Health Study II

Phase 3
Completed
Conditions
Lung Diseases
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease
Interventions
Other: Placebo
First Posted Date
1999-10-28
Last Posted Date
2019-11-01
Lead Sponsor
University of Minnesota
Target Recruit Count
1116
Registration Number
NCT00000569
© Copyright 2025. All Rights Reserved by MedPath